Gary Nabel

Gary Nabel

Director/Board Member at SIGA TECHNOLOGIES, INC.

Net worth: 31 M $ as of 31/08/2026

72 year
Health Technology
Consumer Services
Government

Profile

Dr. Gary J.
Nabel
is an Independent Director at Candel Therapeutics, Inc., a Director & Chief Innovation Officer at OPKO Health, Inc., an Independent Director at SIGA Technologies, Inc. and a President & Chief Executive Officer at ModeX Therapeutics, Inc. He is on the Board of Directors at Candel Therapeutics, Inc., OPKO Health, Inc. and SIGA Technologies, Inc. Dr. Nabel was previously employed as a Chief Scientific Officer & Senior Vice President by Sanofi, a Director-Vaccine Research Center by National Institutes of Health, and a Chairman by Keystone Symposia.
He received his undergraduate degree from Harvard College, a doctorate degree from Harvard University and a doctorate degree from Harvard Medical School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
27/05/2025 21,185,169 ( 2.84% ) 31 M $ 31/08/2026
09/06/2026 73,754 ( 0.1% ) 231 588 $ 31/08/2026
23/06/2026 5,353 ( 0.01% ) 69 964 $ 31/08/2026

Gary Nabel active positions

CompaniesPositionStart
SIGA TECHNOLOGIES, INC. Director/Board Member 15/06/2021
OPKO HEALTH, INC. Director/Board Member 09/05/2022
CANDEL THERAPEUTICS, INC. Director/Board Member 08/08/2022
Chief Executive Officer 01/10/2020

Former positions of Gary Nabel

CompaniesPositionEnd
SANOFI Chief Tech/Sci/R&D Officer 01/11/2020
Corporate Officer/Principal 01/01/2012
Chairman -
See the detail of Gary Nabel's experience

Training of Gary Nabel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

78

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Health Technology

Consumer Services

Government

Health Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Health Technology